371 related articles for article (PubMed ID: 34070429)
1. Assessing the Anti-Inflammatory Activity of the Anxiolytic Drug Buspirone Using CRISPR-Cas9 Gene Editing in LPS-Stimulated BV-2 Microglial Cells.
Thomas Broome S; Fisher T; Faiz A; Keay KA; Musumeci G; Al-Badri G; Castorina A
Cells; 2021 May; 10(6):. PubMed ID: 34070429
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation.
Montoya A; Elgueta D; Campos J; Chovar O; Falcón P; Matus S; Alfaro I; Bono MR; Pacheco R
J Neuroinflammation; 2019 Dec; 16(1):258. PubMed ID: 31810491
[TBL] [Abstract][Full Text] [Related]
3. Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans.
Le Foll B; Payer D; Di Ciano P; Guranda M; Nakajima S; Tong J; Mansouri E; Wilson AA; Houle S; Meyer JH; Graff-Guerrero A; Boileau I
Neuropsychopharmacology; 2016 Jan; 41(2):529-37. PubMed ID: 26089182
[TBL] [Abstract][Full Text] [Related]
4. Ganoderic Acid A Attenuates LPS-Induced Neuroinflammation in BV2 Microglia by Activating Farnesoid X Receptor.
Jia Y; Zhang D; Yin H; Li H; Du J; Bao H
Neurochem Res; 2021 Jul; 46(7):1725-1736. PubMed ID: 33821438
[TBL] [Abstract][Full Text] [Related]
5. β-arrestin2 regulates the anti-inflammatory effects of Salmeterol in lipopolysaccharide-stimulated BV2 cells.
Sharma M; Flood PM
J Neuroimmunol; 2018 Dec; 325():10-19. PubMed ID: 30352316
[TBL] [Abstract][Full Text] [Related]
6. The effects of buspirone on occupancy of dopamine receptors and the rat gambling task.
Di Ciano P; Cormick PM; Stefan C; Wong E; Kim A; Remington G; Le Foll B
Psychopharmacology (Berl); 2017 Nov; 234(22):3309-3320. PubMed ID: 28825117
[TBL] [Abstract][Full Text] [Related]
7. Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in L-DOPA-treated rats.
Azkona G; Sagarduy A; Aristieta A; Vazquez N; Zubillaga V; Ruíz-Ortega JA; Pérez-Navarro E; Ugedo L; Sánchez-Pernaute R
Neuropharmacology; 2014 Apr; 79():726-37. PubMed ID: 24333147
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine Inhibits Neuroinflammation by Altering Microglial M1/M2 Polarization Through MAPK/ERK Pathway.
Qiu Z; Lu P; Wang K; Zhao X; Li Q; Wen J; Zhang H; Li R; Wei H; Lv Y; Zhang S; Zhang P
Neurochem Res; 2020 Feb; 45(2):345-353. PubMed ID: 31823113
[TBL] [Abstract][Full Text] [Related]
9. The Anxiolytic Drug Buspirone Prevents Rotenone-Induced Toxicity in a Mouse Model of Parkinson's Disease.
Thomas Broome S; Castorina A
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163768
[TBL] [Abstract][Full Text] [Related]
10. Anti-neuroinflammatory effects of galangin in LPS-stimulated BV-2 microglia through regulation of IL-1β production and the NF-κB signaling pathways.
Kim ME; Park PR; Na JY; Jung I; Cho JH; Lee JS
Mol Cell Biochem; 2019 Jan; 451(1-2):145-153. PubMed ID: 29995265
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
12. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
García C; Gómez-Cañas M; Burgaz S; Palomares B; Gómez-Gálvez Y; Palomo-Garo C; Campo S; Ferrer-Hernández J; Pavicic C; Navarrete C; Luz Bellido M; García-Arencibia M; Ruth Pazos M; Muñoz E; Fernández-Ruiz J
J Neuroinflammation; 2018 Jan; 15(1):19. PubMed ID: 29338785
[TBL] [Abstract][Full Text] [Related]
13. The Mycobacterial Adjuvant Analogue TDB Attenuates Neuroinflammation via Mincle-Independent PLC-γ1/PKC/ERK Signaling and Microglial Polarization.
Mohanraj M; Sekar P; Liou HH; Chang SF; Lin WW
Mol Neurobiol; 2019 Feb; 56(2):1167-1187. PubMed ID: 29876879
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells.
Zhang J; Zheng Y; Luo Y; Du Y; Zhang X; Fu J
Mol Immunol; 2019 Dec; 116():29-37. PubMed ID: 31590042
[TBL] [Abstract][Full Text] [Related]
15. Isovitexin-Mediated Regulation of Microglial Polarization in Lipopolysaccharide-Induced Neuroinflammation via Activation of the CaMKKβ/AMPK-PGC-1α Signaling Axis.
Liu B; Huang B; Hu G; He D; Li Y; Ran X; Du J; Fu S; Liu D
Front Immunol; 2019; 10():2650. PubMed ID: 31798583
[TBL] [Abstract][Full Text] [Related]
16. Malaysian endophytic fungal extracts-induced anti-inflammation in Lipopolysaccharide-activated BV-2 microglia is associated with attenuation of NO production and, IL-6 and TNF-α expression.
Harun A; Vidyadaran S; Lim SM; Cole AL; Ramasamy K
BMC Complement Altern Med; 2015 Jun; 15():166. PubMed ID: 26047814
[TBL] [Abstract][Full Text] [Related]
17. Mucuna pruriens (L.) DC. seed extract inhibits lipopolysaccharide-induced inflammatory responses in BV2 microglial cells.
Rachsee A; Chiranthanut N; Kunnaja P; Sireeratawong S; Khonsung P; Chansakaow S; Panthong A
J Ethnopharmacol; 2021 Mar; 267():113518. PubMed ID: 33122120
[TBL] [Abstract][Full Text] [Related]
18. Magnesium Lithospermate B Suppresses Lipopolysaccharide-Induced Neuroinflammation in BV2 Microglial Cells and Attenuates Neurodegeneration in Lipopolysaccharide-Injected Mice.
Tai Y; Qiu Y; Bao Z
J Mol Neurosci; 2018 Jan; 64(1):80-92. PubMed ID: 29196883
[TBL] [Abstract][Full Text] [Related]
19. β-Amyrin, the cannabinoid receptors agonist, abrogates mice brain microglial cells inflammation induced by lipopolysaccharide/interferon-γ and regulates Mφ
Askari VR; Fereydouni N; Baradaran Rahimi V; Askari N; Sahebkar AH; Rahmanian-Devin P; Samzadeh-Kermani A
Biomed Pharmacother; 2018 May; 101():438-446. PubMed ID: 29501766
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone sodium phosphate attenuates lipopolysaccharide-induced neuroinflammation in microglia BV2 cells.
Hui B; Yao X; Zhang L; Zhou Q
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1761-1768. PubMed ID: 31915845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
